Can kids with arthritis safely reduce their medication?
NCT ID NCT07190053
Summary
This study aims to understand the best long-term treatment approaches for children and teenagers with specific types of juvenile arthritis (ERA or JPsA) who are taking the drug secukinumab and have achieved inactive disease. Researchers will use data from a German registry to see if treatment can be safely reduced or paused, and how often the disease flares up again. The goal is to learn how to manage the condition effectively over the long term while minimizing medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTHESITIS-RELATED ARTHRITIS (ERA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.